Skip to main content

Allarity Therapeutics, Inc.

corporate_fare Company Profile

Allarity Therapeutics, Inc.

ALLR·NASDAQ·Life Sciences·CIK 0001860657

Allarity is a clinical-stage, precision medicine pharmaceutical company that develops new anti-cancer treatments for patients with significant unmet medical needs. The company's foundation is its proprietary Drug Response Predictor (DRP®) platform. This technology identifies gene expression patterns in cancer cells that indicate how sensitive they are to specific cancer drugs. Once these DRP® gene expression signatures are defined, they can be used to analyze cancer tissue biopsies from patients. This process helps identify cancers that share the drug sensitivity signature, thereby pinpointing patients most likely to benefit from a particular anti-cancer therapeutic. Allarity has developed and published DRP® signatures for dozens of anti-cancer therapeutics. The aim is to use DRP to focus clinical development on smaller, more responsive patient populations, potentially leading to smaller, less expensive, and faster trials, and increasing the likelihood of clinical and regulatory success. Historically, Allarity has created DRP signatures for many anti-cancer therapeutics and in-licensed several assets for DRP-guided development, including Liposomal CisPlatin (LiPlaCis), Irofulven, dovitinib, and the PARP/tankyrase inhibitor, stenoparib. In 2024, Thomas H. Jensen, a co-founder, became Chief Executive Officer, and in 2025, Jeffrey Ervin was hired as Chief Financial Officer.

Allarity Therapeutics, Inc. (NASDAQ:ALLR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for ALLR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-17, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for ALLR spans 8-K, 10-Q, DEFA14A, 424B3.

Recent high-impact activity:

  • Allarity Swaps $3M of Streeterville Debt for Senior Preferred, Gives Lender 33% of ATM Proceeds
  • Allarity Posts $6.2M Q3 Loss as Going-Concern Doubt Deepens
  • Allarity Q3 10-Q Flags Going-Concern Doubt and Nasdaq Equity Deficiency
  • Allarity Settles $4.9M Novartis Liability for $1M; Books First CLIA Lab Contract
  • Allarity Terminates $6.0M Tumim Equity Line, Seeks Alternative Financing

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$320K
Net Income
-$11.23M
Op. Cash Flow
-$14.82M
Free Cash Flow
-$14.83M
Operating Income
-$12.61M
Cash & Equivalents
$14.69M
Debt / Equity
0.00×
Net Margin
-35.10×
Shares Outstanding
16.08M sh
Source: 10-K · filed 2026-03-30 · accession 0001437749-26-010310

Short Interest & Short Volume

1.85 days to cover

FINRA reported short interest of 230,750 shares in ALLR as of the October 30, 2026 settlement, a 37.3% increase from the prior period — about 1.9 days to cover at its recent average daily volume. On November 20, 2026, 25.1% of ALLR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)230,750 shares as of October 30, 2026
Change vs prior period▲ 37.3%
Days to cover1.85 at avg daily volume of 124,971
Daily short volume (FINRA facilities)25.1% of 160,613 shares on November 20, 2026
5-day average short volume33.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$0.80 +1.91% today
52-week range · as of 2026-11-17 $0.7687 – $1.84
Market cap
$12.56M
Volume
306.4K (1.9× avg)
3-mo avg 163.7K
Live data · 2026-11-21 04:44 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed ALLR - Latest Insights

ALLR
Nov 17, 2026, 7:50 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.870
Real-time Price: $0.800 info
Change: -$0.070 (-8%) info
Market Cap: $12.558M info
ALLR
Nov 13, 2026, 8:07 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.950
Real-time Price: $0.800 info
Change: -$0.150 (-16%) info
Market Cap: $12.558M info
ALLR
Nov 13, 2026, 8:05 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.950
Real-time Price: $0.800 info
Change: -$0.150 (-16%) info
Market Cap: $12.558M info
ALLR
Nov 02, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.8415
Real-time Price: $0.800 info
Change: -$0.0415 (-5%) info
Market Cap: $12.558M info
ALLR
Oct 30, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.870
Real-time Price: $0.800 info
Change: -$0.070 (-8%) info
Market Cap: $12.558M info
ALLR
Sep 14, 2026, 12:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.21
Real-time Price: $0.800 info
Change: -$0.410 (-34%) info
Market Cap: $12.558M info
ALLR
Aug 14, 2026, 8:02 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.42
Real-time Price: $0.800 info
Change: -$0.6222 (-44%) info
Market Cap: $12.558M info
ALLR
Jul 01, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.29
Real-time Price: $0.800 info
Change: -$0.490 (-38%) info
Market Cap: $12.558M info
ALLR
Jun 30, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.33
Real-time Price: $0.800 info
Change: -$0.533 (-40%) info
Market Cap: $12.558M info
ALLR
Jun 02, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.72
Real-time Price: $0.800 info
Change: -$0.9196 (-53%) info
Market Cap: $12.558M info
ALLR
May 15, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.42
Real-time Price: $0.800 info
Change: -$0.620 (-44%) info
Market Cap: $12.558M info
ALLR
May 15, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.35
Real-time Price: $0.800 info
Change: -$0.550 (-41%) info
Market Cap: $12.558M info
ALLR
May 15, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.42
Real-time Price: $0.800 info
Change: -$0.620 (-44%) info
Market Cap: $12.558M info
ALLR
May 05, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.30
Real-time Price: $0.800 info
Change: -$0.500 (-38%) info
Market Cap: $12.558M info
ALLR
Apr 30, 2026, 5:28 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $1.37
Real-time Price: $0.800 info
Change: -$0.570 (-42%) info
Market Cap: $12.558M info
ALLR
Apr 28, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.37
Real-time Price: $0.800 info
Change: -$0.570 (-42%) info
Market Cap: $12.558M info
ALLR
Apr 27, 2026, 7:44 AM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $1.38
Real-time Price: $0.800 info
Change: -$0.580 (-42%) info
Market Cap: $12.558M info
ALLR
Apr 21, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.21
Real-time Price: $0.800 info
Change: -$0.410 (-34%) info
Market Cap: $12.558M info
ALLR
Apr 10, 2026, 5:18 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.24
Real-time Price: $0.800 info
Change: -$0.435 (-35%) info
Market Cap: $12.558M info
ALLR
Mar 30, 2026, 5:29 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.06
Real-time Price: $0.800 info
Change: -$0.260 (-25%) info
Market Cap: $12.558M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets